1 / 8

Endoscope Radiofrequency Ablation (RFA) Market Expected to Reach $7,471 Million by 2025

The global endoscope radiofrequency ablation (RFA) market was valued at $3,567 million in 2017 and is estimated to reach at $7,471 million by 2025, registering a CAGR of 9.6% from 2018 to 2025. Endoscope radiofrequency ablation (RFA) is an advanced treatment modality in which endoscope devices are used in conjunction with radiofrequency ablation devices for the treatment of cardiac disorders, oncological disorders, and pain management. The potential of endoscopic RFA is being evaluated in the treatment of early esophageal squamous intra-epithelial neoplasia along with gastric diseases, rectal diseases, and biliary diseases.<br>

srushtih123
Download Presentation

Endoscope Radiofrequency Ablation (RFA) Market Expected to Reach $7,471 Million by 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023 Endoscope + Radiofrequency Ablation (RFA) Market : A Renewed Interest in New Technology Global Opportunity Analysis and Industry Forecast, 2017-2025

  2. Endoscope +Radiofrequency Ablation (RFA) Market “The emerging novel or advanced electrosurgical units applied in radiofrequency ablation treatments is set to boost the demand for RFA treatment across various medical indications. In addition, the endoscopic RFA is set to open new avenues in the treatment of patients suffering from Barrett‐™s esophagus while decreasing the length of surgery.”

  3. Endoscope +Radiofrequency Ablation (RFA) Market Overview According to a new report published by Allied Market Research, titled, Endoscope + Radiofrequency Ablation (RFA) Market by Application: Global Opportunity Analysis and Industry Forecast, 2017-2025, the global endoscope + radiofrequency ablation (RFA) market was valued at $3,567 million in 2017 and is projected to reach $7,471 million by 2025, growing at a CAGR of 9.6% from 2018 to 2025. North America was the highest revenue contributor in 2017 and is expected to maintain this trend throughout the forecast period. Access Full Summary : https://www.alliedmarketresearch.com/endoscope-radiofrequency-ablation-RFA-market Radiofrequency ablation (RFA) utilizes thermal energy to accomplish targeted tissue destruction. RFA was initially studied for the treatment of dysplastic Barrettes esophagus (BE) within the gastrointestinal (GI) tract, and this is still considered to be a common application of RFA. In addition, the indications for endoscopic RFA continue to evolve. 

  4. Endoscope +Radiofrequency Ablation (RFA) Market Based on application, the endoscope + radiofrequency ablation (RFA) market is classified into four segments‐oncology application, pain management, cardiology application, and other applications. The cardiology application segment registered the highest revenue in 2017 and is expected to maintain this trend throughout the forecast period. The dominant position of this segment in the global market is majorly contributed by the increase in the patient pool suffering from arrhythmia. Whereas, the oncology application segment is expected to record the highest CAGR from 2018 to 2025.  

  5. Endoscope +Radiofrequency Ablation (RFA) Market Key Players The report provides a comprehensive analysis of the key players operating in the global endoscope + radiofrequency ablation (RFA) market, such as Boston Scientific Corporation Conmed Corporation, Medtronic Plc (Covidien Plc), Smith & Nephew Plc, Stryker Corporation, Halyard Health, Inc., Abbott Laboratories (St. Jude Medical, Inc.), AngioDynamics, Inc., Hologic, Inc, and AtriCure, Inc. Other prominent players in the value chain include Diros Technology, Inc., Arthrex, Inc., Biotronik, Cosman Medical, Inc., Fcare Systems, Johnson & Johnson (Biosense Webster & DePuyMitek), Stockert GmbH, and ENDO-FLEX GmbH. 

  6. Key Benefits of Endoscope +Radiofrequency Ablation (RFA) Market • The study provides an in-depth analysis with the current trends and future estimations of the global endoscope + radiofrequency ablation (RFA) market. • A comprehensive analysis of the factors that drive and restrict the market growth is provided. • The quantitative analysis of the industry from 2017 to 2025 is provided to enable the stakeholders to capitalize on the prevailing market opportunities. • An extensive analysis of key segments of the industry is provided to understand the applications of endoscope + radiofrequency ablation (RFA) used globally. • The key players and their strategies are analyzed to understand the competitive outlook of the market. 

  7. Endoscope +Radiofrequency Ablation (RFA) Market North America Europe Asia-Pacific LAMEA

  8. Endoscope +Radiofrequency Ablation (RFA) Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/request-sample/4705 Follow Us On

More Related